<?xml version="1.0" encoding="UTF-8"?>
<ref id="B31-viruses-12-00581">
 <label>31.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gocnik</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Fislova</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Sladkova</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Mucha</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Kostolansky</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Vareckova</surname>
    <given-names>E.</given-names>
   </name>
  </person-group>
  <article-title>Antibodies specific to the HA2 glycopolypeptide of influenza A virus haemagglutinin with fusion-inhibition activity contribute to the protection of mice against lethal infection</article-title>
  <source>J. Gen. Virol.</source>
  <year>2007</year>
  <volume>88</volume>
  <fpage>951</fpage>
  <lpage>955</lpage>
  <pub-id pub-id-type="doi">10.1099/vir.0.82563-0</pub-id>
  <?supplied-pmid 17325369?>
  <pub-id pub-id-type="pmid">17325369</pub-id>
 </element-citation>
</ref>
